SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001839882-22-020277
Filing Date
2022-09-09
Accepted
2022-09-09 17:12:14
Documents
6

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT admp-s3_090922.htm S-3 600782
2 FORM OF INDENTURE ex4-3.htm EX-4.3 363439
3 OPINION OF LATHAM & WATKINS, LLP ex5-1.htm EX-5.1 28174
4 CONSENT OF BDO USA, LLP ex23-2.htm EX-23.2 5052
5 GRAPHIC ex5-1_01.jpg GRAPHIC 3750
6 FEE TABLE ex107.htm EX-FILING FEES 29197
  Complete submission text file 0001839882-22-020277.txt   1033041
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-267365 | Film No.: 221236849
SIC: 2834 Pharmaceutical Preparations